At A Glance
- LL-37 is a human antimicrobial peptide with a wider role in immune signalling. It is studied both for interactions with microbial membranes and for the way it influences the body’s own cells.
- The linked foundational work describes cell recruitment through a formyl-peptide-receptor-like pathway.
- Studies have reported angiogenic activity in experimental models.
What Is LL-37?
LL-37 is a human antimicrobial peptide with a wider role in immune signalling. It is studied both for interactions with microbial membranes and for the way it influences the body’s own cells.
Its structure can interact with certain microbial membranes, while other actions help direct immune-cell movement and signalling. That combination makes LL-37 more than a simple bacteria-versus-peptide story.
Why Does It Come Up In Wound-Response Research?
Tissue response involves microbes, immune cells, blood vessels, and repair signals. LL-37 has been studied across several of those areas, including immune-cell recruitment and blood-vessel formation in experimental models.
Does Antimicrobial Activity Tell The Whole Story?
No. The surrounding salt, serum, tissue, and organism can change how it behaves, and host cells may also respond. Understanding both the microbial and immune sides gives a fuller explanation of why LL-37 interests researchers.
A Closer Look At LL-37
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Immune-cell research | Recruiting cells | The linked foundational work describes cell recruitment through a formyl-peptide-receptor-like pathway. | This helps explain LL-37’s signalling role beyond membrane activity. |
| Experimental tissue models | Blood-vessel formation | Studies have reported angiogenic activity in experimental models. | The tissue setting matters when interpreting that response. |
Common Questions About LL-37
What is LL-37?+
LL-37 is a human antimicrobial peptide with a wider role in immune signalling. It is studied both for interactions with microbial membranes and for the way it influences the body’s own cells.
Why does it come up in wound-response research?+
Tissue response involves microbes, immune cells, blood vessels, and repair signals. LL-37 has been studied across several of those areas, including immune-cell recruitment and blood-vessel formation in experimental models.
Does antimicrobial activity tell the whole story?+
No. The surrounding salt, serum, tissue, and organism can change how it behaves, and host cells may also respond. Understanding both the microbial and immune sides gives a fuller explanation of why LL-37 interests researchers.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- the primary chemotaxis studyPeer-reviewed publication · Linked record
A foundational study showed chemotactic activity through a formyl-peptide receptor-like pathway, helping establish LL-37 as more than a simple membrane antibiotic.
- the primary angiogenesis studyPeer-reviewed publication · Linked record
LL-37 promoted angiogenesis in experimental models, illustrating why one peptide can be relevant to wound response yet potentially problematic in other disease settings.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For LL-37 context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Vote For LL-37
This compound is not currently stocked. Add it to your five-choice catalogue ballot.